Although more than 600 ACCP colleagues have joined the ACCP PBRN, only a handful of ACCP associates are participating in the Medication Error Detection, Amelioration, and Prevention (MEDAP) Study, launched on August 5, 2010. It is not too late to make a difference by joining the MEDAP Study.

What is the purpose of the MEDAP Study?

The MEDAP Study was formed with the intent of gathering information regarding the interventions made by clinical pharmacists across the country that are related to medication error detection, amelioration, and prevention.

What will I be asked to do in the MEDAP Study?

For the MEDAP Study, the ACCP PBRN pharmacist is the study subject. As a participating pharmacist, you will be asked to collect data about any intervention made pertaining to medication errors during a consecutive 14-day period. For each intervention related to a medication error detection, prevention, or amelioration during these 14 days, you will be asked a series of questions. For example, data will be collected about the type of error (or prevented error), the intervention(s) made, the medication(s) involved, and the patient outcome(s), if known. However, only de-identified patient information will be collected.

Is the MEDAP Study IRB approved?

Yes, the AAFP (American Academy of Family Physicians) IRB has reviewed and approved the study. All IRB-related documents are available on the PBRNConnect.

How do I join the MEDAP Study?

First, you must join the ACCP PBRN. Go to accpri.org to join by answering questions pertaining to you, your practice site, and the clinical services you provide. You can complete the registry tool from within the PBRNConnect (www.accpri.org/pbrnconnect).

I’ve joined the ACCP PBRN. What else do I need to do?

Once you join the registry, you need to complete a portfolio with the PBRNConnect that will make you eligible to participate in any PBRN project (www.accpri.org/pbrnconnect).

What is the PBRNConnect?

The PBRNConnect is the name given to the one-stop resource created for all PBRN-related materials. Located at www.accpri.org/pbrnconnect, this resource allows ACCP PBRN members to view, print, and download all research and PBRN-related documents. In addition, the PBRNConnect will serve as a repository for all PBRN-related training. Each ACCP PBRN member will need to upload his/her own portfolio documents within the secure PBRNConnect site to participate in ACCP PBRN studies. ACCP PBRN members will access this site using their usual ACCP.com log-in.

How do I get my MEDAP Study log-in and password?

All eligible ACCP PBRN members who have completed all required steps within PBRNConnect will receive a unique Discovere user name and password through e-mail.

What are the anticipated study dates for the MEDAP Study?

How will I be trained to do ACCP PBRN–related projects?

Pharmacists may access all training materials online on the PBRNConnect. Before entering any study data, you will be asked to watch the two new training videos located at www.accpri.org/pbrnconnect. There, you will find the brief Module 3: Introduction to Discovere, and under step 4, you will find MEDAP Study Training Module. You can also print the new MEDAP PocketGuide to help you with data collection at your clinical practice site.

I have more questions. Where can I send them?

Contact us at [email protected] with any questions. Thank you for your interest in the ACCP PBRN MEDAP Study.